GlobalData on MSN9h
Sanofi’s $17bn sale of Opella to US investors advances following government deal
A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...
FiercePharma9h
Sanofi in 'exclusive negotiations' to sell 50% stake in €16B consumer health unit Opella
Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% ...
Sanofi Pursues Sale Of Painkiller After Political Controversy
Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, ...
BioSpace7h
Sanofi Seals Deal With Private Equity Firm for 50% Stake in Consumer Healthcare Unit
Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French ...
cnbctv1812h
Sanofi to sell 50% of Opella in $17 billion deal with CD&R, job guarantees for France included
Sanofi, which is joining a growing number of drugmakers shedding consumer related businesses, said Opella had been valued at ...
Drug Store News1d
Sanofi, CD&R partner to support Opella’s growth in consumer health care
Sanofi and CD&R are joining forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have entered exclusive negotiations for the ...
Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare
Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcareSanofi and CD&R enter exclusive negotiations to transfer a 50% ...
Sanofi reaches deal on terms of sale of consumer health arm, say French government sources
Sanofi agrees to sell a 50% stake in Opella to CDR for €15bn, securing job promises. Discover the impact on France ...
Sanofi confirms €16 billion sale of painkiller Doliprane to US investors
French pharamceutical giant Sanofi has confirmed plans to sell a controlling stake in its over-the-counter unit to a US ...